Inventor · disambiguated record
Heinz W. Pauls
Also filed as: PAULS HEINZ · PAULS HEINZ W · PAULS HEINZ WERNER
49 granted patents·13 pending applications·565 citations·filing 1983–2023
98Inventor score
Files withUNIV HEALTH NETWORK32AVENTIS PHARMA INC5PAULS HEINZ W5AFFINIUM PHARM INC2DEBIOPHARM INT SA2
Top patents by PatentIndex Score
62 records- 0195US8263596B2Kinase inhibitors and method of treating cancerSAMPSON PETER B·Filed 2011·Granted Sep 11, 2012·26 cites·10 claims
- 0294US9657025B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2015·Granted May 23, 2017·11 cites·2 claims
- 0394US9139563B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2013·Granted Sep 22, 2015·14 cites·9 claims
- 0494US8481533B2Kinase inhibitors and method of treating cancerSAMPSON PETER B·Filed 2012·Granted Jul 9, 2013·24 cites·20 claims
- 0593US6323227B1Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amidesAVENTIS PHARM PROD INC·Filed 1999·Granted Nov 27, 2001·76 cites·61 claims
- 0693US5055451AAryloxy and arylacyloxy methyl ketones as thiol protease inhibitorsSYNTEX INC·Filed 1987·Granted Oct 8, 1991·83 cites·50 claims
- 0792US9907800B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2015·Granted Mar 6, 2018·7 cites·6 claims
- 0892US9573954B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2013·Granted Feb 21, 2017·13 cites·22 claims
- 0991US8481525B2Kinase inhibitors and method of treating cancer with sameSAMPSON PETER BRENT·Filed 2010·Granted Jul 9, 2013·27 cites·33 claims
- 1090US10358436B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2018·Granted Jul 23, 2019·4 cites·6 claims
- 1190US9884855B2Salt and crystal forms of PLK-4 inhibitorUNIV HEALTH NETWORK·Filed 2014·Granted Feb 6, 2018·8 cites·20 claims
- 1290US8999968B2Kinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2013·Granted Apr 7, 2015·13 cites·13 claims
- 1389US10919886B2Salt and crystal forms of PLK-4 inhibitorUNIV HEALTH NETWORK·Filed 2019·Granted Feb 16, 2021·2 cites·22 claims
- 1489US8921545B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesCUMMING GRAHAM·Filed 2011·Granted Dec 30, 2014·15 cites·14 claims
- 1589US8765748B2Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancerPAULS HEINZ W·Filed 2008·Granted Jul 1, 2014·16 cites·17 claims
- 1688US10501474B2HPK1 inhibitors and methods of using sameUNIV HEALTH NETWORK·Filed 2016·Granted Dec 10, 2019·3 cites·2 claims
- 1788US6281227B1Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compoundsAVENTIS PHARMA GMBH·Filed 1999·Granted Aug 28, 2001·44 cites·34 claims
- 1888US2024287077A1Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2023·Application pending·0 cites
- 1987US10472353B2Salt and crystal forms of PLK-4 inhibitorUNIV HEALTH NETWORK·Filed 2019·Granted Nov 12, 2019·3 cites·20 claims
- 2087US10106545B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2017·Granted Oct 23, 2018·4 cites·21 claims
- 2187US9796703B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2017·Granted Oct 24, 2017·4 cites·9 claims
- 2286US10584130B2Solid forms of TTK inhibitorUNIV HEALTH NETWORK·Filed 2017·Granted Mar 10, 2020·2 cites·22 claims
- 2386USRE47731EKinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2018·Granted Nov 19, 2019·4 cites·13 claims
- 2486US10392374B2Salt and crystal forms of PLK-4 inhibitorUNIV HEALTH NETWORK·Filed 2018·Granted Aug 27, 2019·3 cites·17 claims
- 2586US9579327B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2014·Granted Feb 28, 2017·5 cites·16 claims
- 2684US11104681B2Solid forms of TTK inhibitorUNIV HEALTH NETWORK·Filed 2020·Granted Aug 31, 2021·1 cites·19 claims
- 2784US10570143B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2018·Granted Feb 25, 2020·2 cites·21 claims
- 2884US10167289B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2017·Granted Jan 1, 2019·2 cites·16 claims
- 2984US8318720B2Acrylamide derivatives as Fab I inhibitorsPAULS HEINZ W·Filed 2007·Granted Nov 27, 2012·7 cites·34 claims
- 3084US6977263B2Chemical compoundsAVENTIS PHARMA INC·Filed 2001·Granted Dec 20, 2005·27 cites·59 claims
- 3183US10077255B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2017·Granted Sep 18, 2018·2 cites·25 claims
- 3282US7790709B2Heterocyclic compounds, methods of making them and their use in therapyAFFINIUM PHARM INC·Filed 2003·Granted Sep 7, 2010·12 cites·14 claims
- 3382US5158936AAryloxy and arylacyloxy methyl ketones as thiol protease inhibitorsSYNTEX INC·Filed 1991·Granted Oct 27, 1992·44 cites·11 claims
- 3481US8980934B2Kinase inhibitors and method of treating cancer with samePAULS HEINZ W·Filed 2013·Granted Mar 17, 2015·3 cites·21 claims
- 3580US6034093ASubstituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compoundsRHONE POULENC RORER PHARMA·Filed 1998·Granted Mar 7, 2000·28 cites·30 claims
- 3679US11878980B2Solid forms of TTK inhibitorUNIV HEALTH NETWORK·Filed 2021·Granted Jan 23, 2024·0 cites·8 claims
- 3779US8895545B2Acrylamide derivatives as Fab I inhibitorsAFFINIUM PHARM INC·Filed 2012·Granted Nov 25, 2014·2 cites·20 claims
- 3879US2022204511A1Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2021·Application pending·0 cites
- 3977US11667627B2Salt and crystal forms of PLK-4 inhibitorUNIV HEALTH NETWORK·Filed 2021·Granted Jun 6, 2023·0 cites·11 claims
- 4074US5731315ASubstituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compoundsRHONE POULENC RORER PHARMA·Filed 1996·Granted Mar 24, 1998·20 cites·44 claims
- 4173US2021009595A1Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2020·Application pending·0 cites
- 4269US11059832B2HPK1 inhibitors and methods of using sameUNIV HEALTH NETWORK·Filed 2019·Granted Jul 13, 2021·0 cites·10 claims
- 4369US2022002313A1Hpk1 inhibitors and methods of using sameUNIV HEALTH NETWORK·Filed 2021·Application pending·0 cites
- 4469US2019322669A1Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2018·Application pending·0 cites
- 4568US10875863B2RIPK2 inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2019·Granted Dec 29, 2020·0 cites·15 claims
- 4667US7612075B2Substituted oxoazaheterocyclyl compoundsAVENTIS PHARMA INC·Filed 2003·Granted Nov 3, 2009·3 cites·15 claims
- 4764US2021261554A1Ripk2 inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2020·Application pending·0 cites
- 4856US10239881B2RIPK2 inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2015·Granted Mar 26, 2019·0 cites·16 claims
- 4954US8410150B2Inhibitors of carnitine palmitoyltransferase and treating cancerPAULS HEINZ W·Filed 2008·Granted Apr 2, 2013·0 cites·20 claims
- 5054US2024317740A1Novel compounds and their useDEBIOPHARM INT SA·Filed 2022·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →